Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 57OTHER 34NIH 5NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Burkitt Lymphoma 6Pancreatic Neoplasms 5Lung Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Wilms Tumor 3Osteosarcoma 3Malignant Solid Neoplasm 3Lymphoma, Non-Hodgkin 3Lymphoma 3Hematologic Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Rhabdomyosarcoma, Embryonal 2Recurrence 2

Interventions

zanubrutinib 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Recurrence × 30 days × Clear all
NCT01790152 2026-05-18

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Oncology Group

Recruiting
420 enrolled
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Recurrence, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07341191 2026-05-14

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Canadian Cancer Trials Group

Phase 2 Recruiting
40 enrolled
Lymphoid

Recurrence, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡